Tailoring a Combination Preerythrocytic Malaria Vaccine

Area of Science:

• Immunology
• Vaccinology
• Infectious Diseases

Background:

• The leading malaria vaccine candidate, RTS,S, targets the Plasmodium falciparum circumsporozoite protein (CSP).
• Current subunit vaccines, including CSP and virus-vectored thrombospondin-related adhesive protein (TRAP), offer limited protection against malaria.
• Developing more effective malaria vaccines is crucial for global health.

Purpose of the Study:

• To investigate the efficacy of combining Plasmodium berghei CSP and TRAP antigens in a prime-boost vaccination strategy.
• To evaluate different prime-boost regimens for delivering CSP and TRAP antigens.
• To determine if combining CSP and TRAP can enhance protection against malaria compared to individual subunit vaccines.

Main Methods:

• Utilized Plasmodium berghei homologues of CSP and TRAP antigens.
• Employed adenovirus- and vaccinia virus-based vectors for TRAP delivery in a prime-boost regime.
• Administered CSP via viral vectors initially, then explored an adenovirus-CSP prime, protein-CSP boost regimen.
• Assessed anti-CSP antibody titers and protective efficacy in C57BL/6 mice.

Main Results:

• Combining virus-vectored TRAP with viral vector-delivered CSP did not improve protection and reduced anti-CSP antibodies.
• An adenovirus-CSP prime followed by a protein-CSP boost significantly increased anti-CSP antibody titers.
• This enhanced CSP prime-boost regimen, when combined with virus-vectored TRAP, provided 100% protection in mice.
• Virus-vectored TRAP alone offered no protection, and the adenovirus-CSP prime/protein-CSP boost alone provided 40% protection.

Conclusions:

• A prime-boost strategy combining CSP and TRAP subunit vaccines can significantly enhance malaria protection.
• The specific regimen, particularly using a protein boost for CSP, is critical for achieving high efficacy.
• This combination approach holds promise for developing more effective malaria vaccines.